These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

224 related items for PubMed ID: 10482942

  • 1. Valuing clinical strategies early in development: a cost analysis of allogeneic peripheral blood stem cell transplantation.
    Bennett C, Waters T, Stinson T, Almagor O, Pavletic Z, Tarantolo S, Bishop M.
    Bone Marrow Transplant; 1999 Sep; 24(5):555-60. PubMed ID: 10482942
    [Abstract] [Full Text] [Related]

  • 2. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL.
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Comparison of allogeneic T cell-depleted peripheral blood stem cell and bone marrow transplantation: effect of stem cell source on short- and long-term outcome.
    Barge RM, Brouwer RE, Beersma MF, Starrenburg CW, Zwinderman AH, Hale G, Waldmann H, den Ottolander GJ, Falkenburg JH, Willemze R, Fibbe WE.
    Bone Marrow Transplant; 2001 May; 27(10):1053-8. PubMed ID: 11438820
    [Abstract] [Full Text] [Related]

  • 5. Costs of hematopoietic cell transplantation: comparison of umbilical cord blood and matched related donor transplantation and the impact of posttransplant complications.
    Majhail NS, Mothukuri JM, Brunstein CG, Weisdorf DJ.
    Biol Blood Marrow Transplant; 2009 May; 15(5):564-73. PubMed ID: 19361748
    [Abstract] [Full Text] [Related]

  • 6. Cost analysis of the introduction of PBPC for autologous transplantation: effect of switching from bone marrow (BM) to peripheral blood progenitor cells (PBPC).
    Bredeson C, Malcolm J, Davis M, Bence-Bruckler I, Kearns B, Huebsch L.
    Bone Marrow Transplant; 1997 Nov; 20(10):889-96. PubMed ID: 9404932
    [Abstract] [Full Text] [Related]

  • 7. Lower costs associated with hematopoietic cell transplantation using reduced intensity vs high-dose regimens for hematological malignancy.
    Saito AM, Zahrieh D, Cutler C, Ho VT, Antin JH, Soiffer RJ, Alyea EP, Lee SJ.
    Bone Marrow Transplant; 2007 Aug; 40(3):209-17. PubMed ID: 17563734
    [Abstract] [Full Text] [Related]

  • 8. Comparative cost analysis of autologous peripheral blood progenitor cell and bone marrow transplantation in pediatric patients with malignancies.
    Vicent MG, Madero L, Chamorro L, Madero R, Diaz MA.
    Haematologica; 2001 Oct; 86(10):1087-94. PubMed ID: 11602415
    [Abstract] [Full Text] [Related]

  • 9. Role of antithymocyte globulin and granulocyte-colony stimulating factor-mobilized bone marrow in allogeneic transplantation for patients with hematologic malignancies.
    Chen XH, Zhang C, Zhang X, Gao L, Gao L, Kong PY, Peng XG, Qi DG, Sun AH, Zeng DF, Liu H, Gong Y, Wang QY.
    Biol Blood Marrow Transplant; 2009 Feb; 15(2):266-73. PubMed ID: 19167687
    [Abstract] [Full Text] [Related]

  • 10. Mucositis after allogeneic hematopoietic stem cell transplantation: a cohort study of methotrexate- and non-methotrexate-containing graft-versus-host disease prophylaxis regimens.
    Cutler C, Li S, Kim HT, Laglenne P, Szeto KC, Hoffmeister L, Harrison MJ, Ho V, Alyea E, Lee SJ, Soiffer R, Sonis S, Antin JH.
    Biol Blood Marrow Transplant; 2005 May; 11(5):383-8. PubMed ID: 15846292
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [A pilot study of G-CSF mobilized allogeneic bone marrow cells plus peripheral blood stem cells transplantation for malignant hematological diseases].
    Chen Y, Huang X, Xu L, Liu D, Zhang Y, Ren H, Guo N, Lu D.
    Zhonghua Yi Xue Za Zhi; 2002 Oct 10; 82(19):1306-9. PubMed ID: 12509932
    [Abstract] [Full Text] [Related]

  • 13. Similar survival following HLA-identical sibling transplantation for standard indication in children with haematologic malignancies: a single center comparison of mobilized peripheral blood stem cell with bone marrow transplantation.
    Meisel R, Enczmann J, Balzer S, Bernbeck B, Kramm C, Schönberger S, Sinha K, Tröger A, Wernet P, Göbel U, Laws HJ, Dilloo D.
    Klin Padiatr; 2005 Oct 10; 217(3):135-41. PubMed ID: 15858704
    [Abstract] [Full Text] [Related]

  • 14. Allogeneic peripheral blood stem cell transplantation in 23 adult patients with hematologic malignancies: a single-center experience.
    Takenaka K, Shinagawa K, Sunami K, Fujii N, Hiramatsu Y, Maeda Y, Nawa Y, Katayama Y, Teshima T, Ishimaru F, Kiura K, Ikeda K, Harada M.
    Int J Hematol; 2000 Oct 10; 72(3):362-70. PubMed ID: 11185996
    [Abstract] [Full Text] [Related]

  • 15. Results of an outpatient-based stem cell allotransplant program using nonmyeloablative conditioning regimens.
    Ruiz-Argüelles GJ, Gómez-Almaguer D, Ruiz-Argüelles A, González-Llano O, Cantú OG, Jaime-Pérez JC.
    Am J Hematol; 2001 Apr 10; 66(4):241-4. PubMed ID: 11279633
    [Abstract] [Full Text] [Related]

  • 16. Cost comparative study of autologous peripheral blood progenitor cells (PBPC) and bone marrow (ABM) transplantations for non-Hodgkin's lymphoma patients.
    Woronoff-Lemsi MC, Arveux P, Limat S, Deconinck E, Morel P, Cahn JY.
    Bone Marrow Transplant; 1997 Dec 10; 20(11):975-82. PubMed ID: 9422478
    [Abstract] [Full Text] [Related]

  • 17. Clinical outcomes and direct hospital costs of reduced-intensity allogeneic transplantation in chronic myeloid leukemia.
    Krejci M, Mayer J, Doubek M, Brychtova Y, Pospisil Z, Racil Z, Dvorakova D, Lengerova M, Horky O, Koristek Z, Dolezal T, Vorlicek J.
    Bone Marrow Transplant; 2006 Oct 10; 38(7):483-91. PubMed ID: 16980996
    [Abstract] [Full Text] [Related]

  • 18. A comparison of related donor peripheral blood and bone marrow transplants: importance of late-onset chronic graft-versus-host disease and infections.
    Anderson D, DeFor T, Burns L, McGlave P, Miller J, Wagner J, Weisdorf D.
    Biol Blood Marrow Transplant; 2003 Jan 10; 9(1):52-9. PubMed ID: 12533742
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.